Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Coats Lonnel received 12,400 Mineralys Therapeutics, Inc. shares as an award (Form 4)

Traded Oct 19, 2026 · Filed Oct 20, 2026

On Oct 19, 2026, Coats Lonnel (Director) received 12,400 Mineralys Therapeutics, Inc. shares as an award, leaving 12,400 shares. Filed Oct 20, 2026 (Form 4).

Awarded
12,400 shares
Holding after
12,400 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 19, 2026Common StockAward12,40012,400Direct

Source

Download original · View original at SEC

Related